Recent data indicates that retatrutide, a innovative medication, could represent a significant improvement in weight reduction . This therapy combines the actions of a GLP-1 receptor and a GIP analog, seemingly offering a enhanced outcome than existing therapies . Study assessments have shown encouraging findings , including significant reductions